Cutler Group LP Celldex Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$22.61 - $40.65 $382,109 - $686,985	16,900 Added 625.93%	19,600 $4,000
Q3 2023 Nov 07, 2023	SELL	$25.45 - $37.46 $10,180 - $14,984	-400 Reduced 12.9%	2,700 $16,000
Q2 2023 Jul 18, 2023	BUY	$30.29 - $38.28 $30,290 - $38,280	1,000 Added 47.62%	3,100 $22,000
Q1 2023 May 01, 2023	SELL	$34.78 - $47.43 $177,378 - $241,893	-5,100 Reduced 70.83%	2,100 $16,000
Q4 2022 Feb 07, 2023	SELL	$27.78 - $45.38 $2,778 - $4,538	-100 Reduced 1.37%	7,200 $3,000
Q3 2022 Oct 25, 2022	BUY	$22.7 - $37.57 $77,180 - $127,738	3,400 Added 87.18%	7,300 $22,000
Q2 2022 Aug 04, 2022	BUY	$20.5 - $37.33 $10,250 - $18,665	500 Added 14.71%	3,900 $66,000
Q1 2022 Apr 14, 2022	SELL	$27.64 - $39.32 $102,268 - $145,484	-3,700 Reduced 52.11%	3,400 $59,000
Q4 2021 Jan 18, 2022	BUY	$35.68 - $56.27 $253,328 - $399,517	7,100 New	7,100 $12,000

203

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.